Study wrapper · #727
MOTS-c Protects Against Acetaminophen-induced Liver Injury through the MAPK Signaling Pathway.
Editor's note
In a mouse model of acetaminophen-induced liver injury, researchers found that MOTS-c lowered markers of liver damage (AST, ALT), suppressed inflammatory signalling, restored glutathione, and reduced oxidative stress and hepatocyte death. Both plasma and liver MOTS-c were depleted by acetaminophen. Mechanistically the effect ran through inhibition of MAPK components (ERK, JNK, p38), and co-treatment with MAPK inhibitors abolished the protection, a useful causal check. This remains a single-model preclinical study. These are preclinical findings; human data are needed before any clinical conclusions, and "promising therapeutic candidate" is the authors' framing, not evidence of benefit in people. It fits the broader MOTS-c pattern of easing oxidative and inflammatory tissue injury in rodents.
Plain-language abstract
An overdose of acetaminophen (paracetamol) is a leading cause of sudden liver failure. Researchers tested MOTS-c, a mitochondria-derived peptide, in mice given a toxic dose. The overdose lowered the animals' own MOTS-c in both blood and liver. Giving MOTS-c reduced liver-damage blood markers, calmed inflammation, replenished the protective antioxidant glutathione, cut oxidative stress, and reduced liver-cell death. The team found MOTS-c worked by dialing down a stress-signalling system called the MAPK pathway (its ERK, JNK, and p38 branches); when they blocked that pathway with drugs, MOTS-c no longer helped, supporting the proposed mechanism. Because this was done only in mice, it cannot tell us whether MOTS-c would help people with acetaminophen poisoning, and human studies would be needed first. The findings add to a broader body of animal work suggesting MOTS-c protects stressed tissue by reducing oxidative damage and inflammation.